EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Riluzole Reverses Blood–Testis Barrier Loss to Rescue Chemotherapy–Induced Male Infertility by Binding to TRPC

Rufei Huang, Huan Xia, Wanqing Lin, Zhaoyang Wang, Lu Li, Jingxian Deng, Tao Ye iD, Ziyi Li, Yan Yang iD, Yadong Huang

Cells · 2024

DOI: 10.3390/cells13232016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Rufei Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Jinan University, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Riluzole, Blood-Testis Barrier, Infertility, Male. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Guangzhou Key R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer treatments, including cytotoxic therapy, often result in male infertility, necessitating the development of safe and effective strategies to preserve male reproductive potential during chemotherapy. Notably, our study uncovers the potential of repurposing riluzole, an FDA-approved drug for amyotrophic lateral sclerosis (ALS), in enhancing spermatogenesis. Hence, this research aims to explore the feasibility of utilizing riluzole to alleviate male infertility induced by busulfan (BSF), a commonly used chemotherapy drug. We established a BSF-induced oligospermia model in 4-week-old male mice and found that riluzole could effectively counter the detrimental effects of BSF on sperm production in mice with oligospermia. By restoring blood–testis barrier (BTB) functionality, riluzole improves sperm quality and reduces testicular atrophy. Through transcriptomic and molecular docking analyses, we identify transient receptor potential canonical subfamily member 5 (TRPC5) as a potential target for riluzole-mediated regulation of blood–testis barrier function. These findings propose riluzole as a promising therapeutic option for chemotherapy-induced male infertility, thereby addressing the fertility challenges associated with cancer treatments. Moreover, repurposing riluzole could streamline the drug development process, providing a cost-effective approach with reduced risk compared to developing entirely new drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RiluzoleBlood-Testis BarrierInfertility, MaleMaleAnimalsMiceTRPC Cation ChannelsBusulfanAntineoplastic AgentsMice, Inbred C57BLMolecular Docking SimulationProtein Binding

Stichwörter der Autor:innen

Sertoli cellsTRPC5blood–testis barriermale infertilityriluzolespermatogenesis

Substanzen

RiluzoleTRPC Cation ChannelsBusulfanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Cell Biology, Jinan University, Guangzhou 510632, China.
  • Guangdong Province Key Laboratory of Bioengineering Medicine, Guangzhou 510632, China.

ORCID-Profile: Tao Ye, Yan Yang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Guangzhou Key R&D Program
  • Kea-Area Research and Development Program of Guangdong Province
  • Guangzhou Key R&D Program

Zitieren

APA

Huang, R., Xia, H., Lin, W., Wang, Z., Li, L., Deng, J., Ye, T., Li, Z., Yang, Y., & Huang, Y. (2024). Riluzole Reverses Blood–Testis Barrier Loss to Rescue Chemotherapy–Induced Male Infertility by Binding to TRPC. Cells. https://doi.org/10.3390/cells13232016

Vancouver

Huang R, Xia H, Lin W, Wang Z, Li L, Deng J, et al. Riluzole Reverses Blood–Testis Barrier Loss to Rescue Chemotherapy–Induced Male Infertility by Binding to TRPC. Cells. 2024. doi:10.3390/cells13232016

BibTeX
@article{Huang2024,
  author = {Huang, Rufei and Xia, Huan and Lin, Wanqing and Wang, Zhaoyang and Li, Lu and Deng, Jingxian and Ye, Tao and Li, Ziyi and Yang, Yan and Huang, Yadong},
  title = {Riluzole Reverses Blood–Testis Barrier Loss to Rescue Chemotherapy–Induced Male Infertility by Binding to TRPC},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13232016}
}
Kostenlos starten →